HALO position history
The shares of Halozyme Therapeutics (HALO) that TORRAY INVESTMENT PARTNERS LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2021 Q3: 46,669 shares, $1.9M, 0.29% of portfolio
- 2021 Q4: 35,850 shares, $1.4M, 0.21% of portfolio, Reduce −23.2%
- 2022 Q1: 37,820 shares, $1.5M, 0.24% of portfolio, Add +5.5%
- 2022 Q2: 28,293 shares, $1.2M, 0.24% of portfolio, Reduce −25.2%
- 2022 Q3: 32,913 shares, $1.3M, 0.26% of portfolio, Add +16.3%
- 2022 Q4: 31,495 shares, $1.8M, 0.32% of portfolio, Reduce −4.3%
- 2023 Q1: 24,714 shares, $944K, 0.17% of portfolio, Reduce −21.5%
- 2023 Q2: 24,959 shares, $900K, 0.16% of portfolio, Add +1.0%
- 2023 Q3: 26,005 shares, $993K, 0.18% of portfolio, Add +4.2%
- 2023 Q4: 39,886 shares, $1.5M, 0.24% of portfolio, Add +53.4%
- 2024 Q1: 152,089 shares, $3.9M, 0.58% of portfolio, Add +281.3%
- 2024 Q2: 50,748 shares, $2.7M, 0.40% of portfolio, Reduce −66.6%
- 2024 Q3: 55,258 shares, $3.2M, 0.44% of portfolio, Add +8.9%
- 2024 Q4: 55,611 shares, $2.7M, 0.38% of portfolio, Add +0.6%
- 2025 Q1: 55,384 shares, $3.5M, 0.53% of portfolio, Reduce −0.4%
- 2025 Q2: 40,048 shares, $2.1M, 0.30% of portfolio, Reduce −27.7%
- 2025 Q3: 38,121 shares, $2.8M, 0.38% of portfolio, Reduce −4.8%
- 2025 Q4: 38,135 shares, $2.6M, 0.37% of portfolio, Add 0.0%
- 2026 Q1: 38,179 shares, $2.5M, 0.36% of portfolio, Add +0.1%
- 2026 Q2: 38,703 shares, $3M, 0.41% of portfolio, Add +1.4%
- 2026 Q3: 38,540 shares, $4.3M, 0.56% of portfolio, Reduce −0.4%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|